NAMI-A
CAS: 201653-76-1
Rif. 3D-BIA65376
1mg | 338,00 € | ||
5mg | 458,00 € | ||
10mg | 732,00 € | ||
25mg | 1.232,00 € | ||
50mg | 1.970,00 € |
Informazioni sul prodotto
- Ruthenate(1-), tetrachloro(1H-imidazole-κN3)[(sulfinyl-κS)bis[methane]]-, (OC-6-11)-, hydrogen, compd. with 1H-imidazole (1:1)
- Ruthenate(1-), tetrachloro(1H-imidazole-κN3)[1,1′-(sulfinyl-κS)bis[methane]]-, (OC-6-11)-, hydrogen, compd. with 1H-imidazole (1:1:1)
- 1H-Imidazole (OC-6-11)-tetrachloro(1H-imidazole-κN3)[1,1′-(sulfinyl-κS)bis[methane]]ruthenate(1-) (1:1)
- 1H-Imidazole, mono[(OC-6-11)-tetrachloro(1H-imidazole-κN3)[(sulfinyl-κS)bis[methane]]ruthenate(1-)]
Nami-A is an experimental drug that has been shown to have significant cytotoxicity against carcinoma cell lines and solid tumours. Nami-A is a small molecule that binds to integrin receptors on the surface of cells, inhibiting the production of matrix metalloproteinase-9 (MMP-9). In vivo studies with Nami-A in mice showed that mitochondrial membrane potential was reduced and there was a decrease in redox potentials. The MMP-9 inhibition by Nami-A may be due to its ability to inhibit oxidative stress.
Proprietà chimiche
Richiesta tecnica su: 3D-BIA65376 NAMI-A
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.